US213428A
(en)
*
|
|
1879-03-18 |
|
Improvement in harrow-teeth |
US568885A
(en)
*
|
|
1896-10-06 |
|
Can-seaming mechanism |
US4032526A
(en)
|
1975-10-02 |
1977-06-28 |
American Cyanamid Company |
1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
|
GB2068961B
(en)
|
1980-02-13 |
1983-11-30 |
Sankyo Co |
Quinazoline derivatives
|
DE3517617A1
(de)
|
1985-05-15 |
1986-11-20 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
|
JPS6319745Y2
(sl)
|
1985-11-07 |
1988-06-01 |
|
|
JPS61165445A
(ja)
|
1986-01-08 |
1986-07-26 |
株式会社巴組鐵工所 |
振動を減少しうる床構造
|
US5096916A
(en)
|
1990-05-07 |
1992-03-17 |
Aegis Technology, Inc. |
Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
|
US5631269A
(en)
|
1992-10-23 |
1997-05-20 |
Merck Sharp & Dohme Limited |
Dopamine receptor subtype ligands
|
JP3166376B2
(ja)
|
1993-02-03 |
2001-05-14 |
松下電器産業株式会社 |
熱利用装置
|
US5629235A
(en)
|
1995-07-05 |
1997-05-13 |
Winbond Electronics Corporation |
Method for forming damage-free buried contact
|
TW531537B
(en)
|
1995-12-27 |
2003-05-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
DE69842058D1
(de)
|
1997-10-27 |
2011-01-27 |
Neurosearch As |
Heteroaryl Diazacycloalkane als cholinergische Ligande für Nikotin-Acetylcholin-Rezeptoren
|
DK1131318T3
(da)
|
1998-11-20 |
2004-06-01 |
Searle Llc |
Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
RU2299206C9
(ru)
|
1999-05-04 |
2007-11-20 |
Шеринг Корпорейшн |
Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
US20020045613A1
(en)
|
2000-04-27 |
2002-04-18 |
Heinz Pauls |
1-aroyl-piperidinyl benzamidines
|
HU227630B1
(hu)
|
2000-05-22 |
2011-10-28 |
Aventis Pharma Inc |
Arilmetilamin-származékok triptáz gátlóként való alkalmazásra és ezeket tartalmazó gyógyszerkészítmények
|
IL155335A0
(en)
|
2000-10-12 |
2003-11-23 |
Boehringer Ingelheim Pharma |
Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
|
AR035700A1
(es)
|
2001-05-08 |
2004-06-23 |
Astrazeneca Ab |
Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
|
PL208137B1
(pl)
|
2001-06-22 |
2011-03-31 |
Boehringer Ingelheim Pharma |
Bezwodny krystaliczny bromek tiotropium, sposób jego wytwarzania i zastosowanie krystalicznego monohydratu bromku tiotropium do wytwarzania krystalicznego bezwodnego bromku tiotropium
|
WO2003037271A2
(en)
|
2001-10-30 |
2003-05-08 |
Millennium Pharmaceuticals,Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
WO2003066604A2
(en)
|
2002-02-05 |
2003-08-14 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
JP2003240776A
(ja)
|
2002-02-13 |
2003-08-27 |
Horiba Ltd |
クロマトグラフリーダを用いる測定方法およびそれに用いる試験片ホルダ並びにクロマトグラフリーダを用いる検査/測定装置
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
US20030195192A1
(en)
|
2002-04-05 |
2003-10-16 |
Fortuna Haviv |
Nicotinamides having antiangiogenic activity
|
PL220783B1
(pl)
|
2002-03-13 |
2016-01-29 |
Janssen Pharmaceutica Nv |
Pochodna sulfonylowa, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
US20050245537A1
(en)
|
2002-04-24 |
2005-11-03 |
Noboru Tsuchimori |
Use of compounds having ccr antagonism
|
JP3780291B2
(ja)
|
2002-04-29 |
2006-05-31 |
メルク エンド カムパニー インコーポレーテッド |
テトラヒドロピラニルシクロペンチルテトラヒドロピリドピリジン系のケモカイン受容体活性調節剤
|
BR0311619A
(pt)
|
2002-06-05 |
2005-03-08 |
Pharmacia Corp |
Derivados de pirazol como inibidores de cinase p38
|
AU2003270199A1
(en)
|
2002-09-13 |
2004-04-30 |
Glaxo Group Limited |
Urea compounds active as vanilloid receptor antagonists for the treatment of pain
|
SE0203304D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Coumpounds
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
US20040147561A1
(en)
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
WO2004074438A2
(en)
*
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
EA009469B1
(ru)
|
2003-03-12 |
2007-12-28 |
Кудос Фармасеутикалс Лимитед |
Производные фталазинона
|
CA2523431A1
(en)
|
2003-04-23 |
2004-11-25 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
FR2854158B1
(fr)
|
2003-04-25 |
2006-11-17 |
Sanofi Synthelabo |
Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
|
ATE370135T1
(de)
|
2003-07-18 |
2007-09-15 |
Glaxo Group Ltd |
Substituierte piperidine als histamin-h3- rezeptorliganden
|
RU2006101452A
(ru)
|
2003-07-29 |
2006-06-27 |
Ново Нордиск А/С (DK) |
Пиридазинил-пиперазины и их применение в качестве лигандов h3 гистаминового рецептора
|
CN1893945A
(zh)
|
2003-12-18 |
2007-01-10 |
因赛特公司 |
作为趋化因子受体调控剂的3-环烷基氨基吡咯烷衍生物
|
GB0403155D0
(en)
|
2004-02-12 |
2004-03-17 |
Vernalis Res Ltd |
Chemical compounds
|
US7435830B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
MXPA06011414A
(es)
|
2004-03-31 |
2007-04-20 |
Johnson & Johnson |
Compuestos heterociclicos sin imidazol como ligandos del receptor de h3 histamina.
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
JP2008502719A
(ja)
|
2004-05-21 |
2008-01-31 |
メルク エンド カムパニー インコーポレーテッド |
アミノシクロペンチル複素環および炭素環系ケモカイン受容体活性調節剤
|
US7507740B2
(en)
|
2004-06-02 |
2009-03-24 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
FR2871157A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Produits biaryl aromatiques, compositions les contenant et utilisation
|
EP1758580A4
(en)
|
2004-06-24 |
2008-01-16 |
Incyte Corp |
N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT
|
UA85597C2
(ru)
|
2004-06-25 |
2009-02-10 |
Янссен Фармацевтика Н.В. |
Четвертичные соли как антагонисты ccr2
|
CN1976707A
(zh)
*
|
2004-06-28 |
2007-06-06 |
因赛特公司 |
作为趋化因子受体调节剂的3-氨基环戊烷甲酰胺类
|
WO2006004741A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Incyte Corporation |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
MX2007002318A
(es)
|
2004-08-26 |
2007-04-17 |
Kudos Pharm Ltd |
Derivados de ftalazinona substituidos con 4-heteroarilmetilo.
|
GB0420831D0
(en)
|
2004-09-17 |
2004-10-20 |
Glaxo Group Ltd |
Novel compounds
|
JP4958786B2
(ja)
|
2004-09-20 |
2012-06-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
複素環誘導体および治療薬としてのそれらの使用
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
EP2592075B1
(en)
|
2004-11-02 |
2015-04-29 |
Northwestern University |
Pyridazine compounds for the treatment of inflammatory diseases
|
UY29219A1
(es)
|
2004-11-22 |
2006-04-28 |
Incyte Corp |
Sales de la n-(2- (((3r)-1-(trans-4-hidroxi-4-(6-metoxipiridin-3-il)-cilohexil) pirrolidin-3-il)amino)-2-oxoetil)-3- (trifluorometil) benzamida
|
DE102004061751A1
(de)
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Cyanoguanidin-substituierte Pyrazoline
|
RU2408581C2
(ru)
|
2005-02-17 |
2011-01-10 |
Астеллас Фарма Инк. |
Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное
|
EP1879881A2
(en)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
US20070032475A1
(en)
|
2005-04-15 |
2007-02-08 |
Ye Xiaocong M |
Novel compounds useful for bradykinin B1 receptor antagonism
|
CA2606288A1
(en)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
US8921376B2
(en)
|
2005-05-20 |
2014-12-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
ES2375929T3
(es)
|
2005-07-04 |
2012-03-07 |
High Point Pharmaceuticals, Llc |
Antagonistas del receptor histamina h3.
|
CA2606004A1
(en)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
GB0517184D0
(en)
|
2005-08-22 |
2005-09-28 |
Glaxo Group Ltd |
Compounds
|
TWI329641B
(en)
|
2005-08-31 |
2010-09-01 |
Otsuka Pharma Co Ltd |
(benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
NZ566862A
(en)
|
2005-09-27 |
2010-12-24 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of C-kit receptors
|
JO2769B1
(en)
|
2005-10-26 |
2014-03-15 |
جانسين فارماسوتيكا ان. في |
Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
|
US20100016289A1
(en)
|
2005-11-01 |
2010-01-21 |
Kevin Sprott |
Compounds Useful as Antagonists of CCR2
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
CA2627900A1
(en)
|
2005-11-14 |
2007-08-16 |
Irm Llc |
Compounds and compositions as lxr modulators
|
US20090182140A1
(en)
*
|
2005-12-02 |
2009-07-16 |
Mitsubishi Tanabe Pharma Corporation |
Alicyclic Heterocyclic Compound
|
AR058554A1
(es)
|
2005-12-20 |
2008-02-13 |
Novartis Ag |
Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
|
IL172838A
(en)
|
2005-12-27 |
2010-06-16 |
Joma Int As |
Methods for production of metal oxide nano particles with controlled properties and nano particles and preparations produced thereby
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
WO2007100851A1
(en)
|
2006-02-28 |
2007-09-07 |
Helicon Therapeutics, Inc. |
Therapeutic compounds
|
EP2024353A2
(en)
|
2006-03-16 |
2009-02-18 |
Pfizer Products Inc. |
Pyrazole compounds
|
CN101466677A
(zh)
|
2006-04-11 |
2009-06-24 |
默克公司 |
二芳基取代的烷烃
|
US7807671B2
(en)
|
2006-04-25 |
2010-10-05 |
Bristol-Myers Squibb Company |
Diketo-piperazine and piperidine derivatives as antiviral agents
|
CA2650704A1
(en)
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Salts of pyridazine compounds
|
CN101472912A
(zh)
|
2006-06-22 |
2009-07-01 |
比奥维特罗姆上市公司 |
作为mnk激酶抑制剂的吡啶和吡嗪衍生物
|
WO2008014199A2
(en)
|
2006-07-28 |
2008-01-31 |
Boehringer Ingelheim International Gmbh |
Sulfonyl compounds which modulate the cb2 receptor
|
GB0617575D0
(en)
|
2006-09-06 |
2006-10-18 |
Syngenta Ltd |
Herbicidal compounds and compositions
|
CA2664310A1
(en)
|
2006-09-25 |
2008-04-03 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
EP2099454A4
(en)
|
2006-11-17 |
2010-11-10 |
Abbott Lab |
AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
|
BRPI0722070A2
(pt)
|
2006-12-28 |
2014-04-08 |
Abbott Lab |
Inibidores de poli(adp-ribose)polimerase
|
AU2008215948A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of AD and related conditions
|
JP4785881B2
(ja)
|
2007-02-27 |
2011-10-05 |
大塚製薬株式会社 |
医薬
|
FR2915552B1
(fr)
|
2007-04-27 |
2009-11-06 |
Technip France |
Conduite tubulaire flexible pour le transport d'hydrocarbures gazeux.
|
JP5603770B2
(ja)
|
2007-05-31 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr2受容体拮抗薬およびその使用
|
BRPI0814403A2
(pt)
|
2007-07-02 |
2015-01-27 |
Hoffmann La Roche |
Devirados de imidazol como antagonistas de receptor ccr2
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
KR101171488B1
(ko)
|
2007-08-22 |
2012-08-07 |
아이알엠 엘엘씨 |
키나제 억제제로서의 2-헤테로아릴아미노-피리미딘 유도체
|
MX2010003621A
(es)
|
2007-10-01 |
2010-04-14 |
Hoffmann La Roche |
N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
|
AU2008309759A1
(en)
|
2007-10-09 |
2009-04-16 |
F. Hoffmann-La Roche Ag |
Chiral CIS-imidazolines
|
US20100218349A1
(en)
|
2007-10-12 |
2010-09-02 |
Whang Jong O |
Tying tool for shoelace
|
WO2009067406A1
(en)
|
2007-11-20 |
2009-05-28 |
Janssen Pharmaceutica N.V. |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
WO2009066084A1
(en)
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2 -morpholinopyrimidines and their use as pi3 kinase inhibitors
|
EP2225223B1
(de)
*
|
2007-11-22 |
2017-01-11 |
Boehringer Ingelheim International GmbH |
Organische verbindungen
|
EP2062889A1
(de)
|
2007-11-22 |
2009-05-27 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verbindungen
|
CA2725657A1
(en)
|
2008-06-18 |
2009-12-23 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl carboxamide derivatives
|
US8536186B2
(en)
|
2008-08-04 |
2013-09-17 |
Chdi Foundation, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
EA201100423A1
(ru)
|
2008-09-02 |
2011-10-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые бензамиды, их получение и их применение в качестве лекарственных средств
|
RU2011116111A
(ru)
|
2008-09-25 |
2012-10-27 |
Бёрингер Ингельхайм Интернациональ Гмбх (De) |
Сульфонилсодержащие соединения, которые селективно модулируют рецептор св2
|
EP2379525B1
(en)
|
2008-12-19 |
2015-07-29 |
Boehringer Ingelheim International GmbH |
Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
|
US20110301143A1
(en)
|
2009-02-23 |
2011-12-08 |
Elise Isabel |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
MX2012006964A
(es)
*
|
2009-12-17 |
2012-07-17 |
Boehringer Ingelheim Int |
Nuevos antagonistas del receptor ccr2 y usos de los mismos.
|
US20130143905A1
(en)
|
2009-12-17 |
2013-06-06 |
Boehringer Ingelheim International Gmbh |
Novel antagonists for ccr2 and uses thereof
|
EP2542539B1
(en)
|
2010-03-05 |
2014-02-26 |
Boehringer Ingelheim International GmbH |
Tetrazole compounds which selectively modulate the cb2 receptor
|
WO2011141477A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
US8877745B2
(en)
|
2010-05-12 |
2014-11-04 |
Boehringer Ingelheim International Gmbh |
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
US8841313B2
(en)
|
2010-05-17 |
2014-09-23 |
Boehringer Ingelheim International Gmbh |
CCR2 antagonists and uses thereof
|
JP5636094B2
(ja)
|
2010-05-25 |
2014-12-03 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ccr2受容体アンタゴニスト
|
EP2576538B1
(en)
|
2010-06-01 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
New CCR2 antagonists
|
EP2721025B1
(en)
|
2011-06-16 |
2015-11-25 |
Boehringer Ingelheim International Gmbh |
New selective ccr2 antagonists
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|
BR112017028492B1
(pt)
*
|
2015-07-02 |
2023-12-26 |
Centrexion Therapeutics Corporation |
Citrato de (4-((3r,4r)-3-metoxitetra-hidro-piran-4- ilamino)piperidin-1-il) (5- metil-6-(((2r, 6s)-6-(p-tolil) tetra-hidro-2h-piran-2-il)metilamino)pirimidin-4-il) metanona, seu uso e seu método de preparação, e composição farmacêutica
|